Inveready invests in Pharmacelera, a deep tech company transforming drug discovery through Quantum Mechanics and Artificial Intelligence — Inveready

Barcelona, February 18, 2026

Inveready has invested in Pharmacelera as part of a €6 million equity financing round executed through its Life Sciences strategy. The round, led by Heran Partners with participation from Clave Capital and Bio&Tech Smart Capital, will support the company’s expansion into the U.S. market and the continued development of its proprietary Quantum Mechanics and Artificial Intelligence platform, QaiM, designed to accelerate and enhance drug discovery.

View More

Back to News